Dr. Christopher Ames to Join Aclarion as a Key Opinion : vim

Broomfield, CO, Dec. 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare...

Related Keywords

California , United States , Aclarion Nociscan , Christopher Ames , Jodi Lamberti , Company Prospectus , Exchange Commission On , National Institutes Of Health , Nasdaq , Exchange Commission , Spine Center , Aclarion Inc , High Risk Spine Service , Securities Exchange , University Of California At San Francisco , Advisory Inc , Neurospinal Disorders Program , Spinal Deformity , Spine Tumor Surgery , Combined High Risk Spine Service , San Francisco , Key Opinion Leader , Brent Ness , National Institutes , Spine Treatments , Magnetic Resonance Spectroscopy , Private Securities Litigation Reform Act , Securities Act , Securities Exchange Act , Nasdaq Acon , Clarion , Nc ,